Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Aug 7, 2009; 15(29): 3664-3669
Published online Aug 7, 2009. doi: 10.3748/wjg.15.3664
Published online Aug 7, 2009. doi: 10.3748/wjg.15.3664
Table 3 Complication between sequential TACE-cryosurgery and cryo-alone groups n (%)
| Patients (n = 420) | TACE-cryosurgery (n = 290) | Cryo-alone (n = 130) | P | |
| Hepatic bleeding | 16 (3.8) | 5 (1.7) | 11 (8.5) | 0.001 |
| Liver crack | 2 (0.5) | 0 | 2 (1.5) | |
| Thrombocytopenia and/or clotting dysfunction | 30 (7.1) | 21 (7.2) | 9 (6.9) | 0.907 |
| Liver failure | 16 (3.8) | 12 (4.1) | 4 (3.1) | 0.599 |
| Acute renal failure with myoglobinuria | 3 (0.7) | 2 (0.7) | 1 (0.7) | |
| Agranulocytosis | 4 (0.9) | 4 (1.4) | 0 | |
| Pneumonia | 25 (0.6) | 17 (5.9) | 8 (6.2) | 0.907 |
| Total | 101 (24.0) | 61 (21.0) | 40 (30.7) | 0.184 |
- Citation: Xu KC, Niu LZ, Zhou Q, Hu YZ, Guo DH, Liu ZP, Lan B, Mu F, Li YF, Zuo JS. Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. World J Gastroenterol 2009; 15(29): 3664-3669
- URL: https://www.wjgnet.com/1007-9327/full/v15/i29/3664.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3664